This scheme illustrates potential therapeutic targets in obesity management by modulating receptors of GLP-1, amylin-calcitonin, and ghrelin pathways
Tirzepatide: Dual Agonist Properties Tirzepatide is a dual GLP-1 and GIP receptor agonist, making it mechanistically distinct from Semaglutide
10.1093/stmcls/sxad010 Summary Keywords diabetic kidney disease (DKD), sodium-glucose co-transporter 2 inhibitors (SGLT2i), finerenone, gut-kidney axis, cardiorenal protection Citation Zhang H, Wang K, Zhao H, Qin B, Cai X, Wu M, Li J and Wang J (2025) Diabetic kidney disease: from pathogenesis to multimodal therapycurrent evidence and future directions
This gives a sense of the financial landscape were dealing with (and why finding savings is so important): Ozempic (semaglutide): Typically around $900$1,000 for a months supply without insurance
Researchers value retatrutide for exploring how simultaneous modulation of these incretin and glucagon pathways can achieve superior outcomes compared to existing dual-agonist profiles, potentially redefining therapeutic strategies for obesity, type 2 diabetes, and related cardiometabolic disorders
The acquisition includes all the manufacturing and testing equipment in Moderes North American manufacturing facilities and all related inventory, including Liquid BioCell, Trim, Burn, Sculpt, and Curb and the rest of the Modere product portfolio